Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Arcese

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Leukemia Research|January 1, 1986
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemiaG Papa, W Arcese, F R Mauro, et al.
Bone Marrow Transplantation|June 1, 1994
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO)G Dini, L Boni, O Abla, et al.
Bone Marrow Transplantation|August 1, 1992
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized studyA Gratwohl, J Hermans, A von Biezen, et al.
Seminars in Hematology|July 1, 1993
Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMTD Niederwieser, W Arcese, G Bandini, et al.
European Journal of Haematology|March 1, 1991
Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual diseaseF Lo Coco, D Diverio, M Frontani, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Bone Marrow Transplantation|December 1, 1989
Italian survey on allogeneic BMT for chronic myeloid leukaemiaW Arcese, F Mandelli, G Papa, et al.
Haematologica|July 1, 1994
Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantationG Pucci, M Martino, F Morabito, et al.
British Journal of Haematology|January 1, 1994
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia PediatricaF Giona, A M Testi, L Annino, et al.
Lancet (London, England)|December 12, 1992
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaF Lo Coco, D Diverio, P P Pandolfi, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Leukemia Research|January 1, 1986
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemiaG Papa, W Arcese, F R Mauro, et al.
Bone Marrow Transplantation|June 1, 1994
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO)G Dini, L Boni, O Abla, et al.
Bone Marrow Transplantation|August 1, 1992
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized studyA Gratwohl, J Hermans, A von Biezen, et al.
Seminars in Hematology|July 1, 1993
Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMTD Niederwieser, W Arcese, G Bandini, et al.
European Journal of Haematology|March 1, 1991
Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual diseaseF Lo Coco, D Diverio, M Frontani, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Bone Marrow Transplantation|December 1, 1989
Italian survey on allogeneic BMT for chronic myeloid leukaemiaW Arcese, F Mandelli, G Papa, et al.
Haematologica|July 1, 1994
Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantationG Pucci, M Martino, F Morabito, et al.
British Journal of Haematology|January 1, 1994
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia PediatricaF Giona, A M Testi, L Annino, et al.
Lancet (London, England)|December 12, 1992
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaF Lo Coco, D Diverio, P P Pandolfi, et al.
Pageof 16